RESEARCH-USE BIOSIMILAR ANTIBODY
Robatumumab
Monoclonal antibody · IgG1
Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research.
TARGETIGF1R
YMonoclonal antibody
CATALOGSC-BS-204
CATALOG NUMBERSC-BS-204
MOLECULAR WEIGHTApprox. 146.36 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research.
Robatumumab is a recombinant research-use antibody directed against IGF1R.